Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q3077133> ?p ?o }
Showing triples 1 to 54 of
54
with 100 triples per page.
- Q3077133 subject Q7071513.
- Q3077133 subject Q7211328.
- Q3077133 subject Q8253301.
- Q3077133 subject Q8418463.
- Q3077133 subject Q9052323.
- Q3077133 abstract "Teriflunomide (trade name Aubagio, marketed by Sanofi) is the active metabolite of leflunomide. Teriflunomide was investigated in the Phase III clinical trial TEMSO as a medication for multiple sclerosis (MS). The study was completed in July 2010. 2-year results were positive. However, the subsequent TENERE head-to-head comparison trial reported that "although permanent discontinuations [of therapy] were substantially less common among MS patients who received teriflunomide compared with interferon beta-1a, relapses were more common with teriflunomide." The drug was approved by the FDA on September 13, 2012 and in the European Union on August 26, 2013.".
- Q3077133 atcPrefix "L04".
- Q3077133 atcSuffix "AA31".
- Q3077133 casNumber "163451-81-8".
- Q3077133 chEBI "68540".
- Q3077133 fdaUniiCode "1C058IKG3B".
- Q3077133 iupacName "(2Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide".
- Q3077133 pubchem "5479847".
- Q3077133 thumbnail Teriflunomide_structure.svg?width=300.
- Q3077133 wikiPageExternalLink www.aubagio.com.
- Q3077133 wikiPageWikiLink Q1063702.
- Q3077133 wikiPageWikiLink Q1150909.
- Q3077133 wikiPageWikiLink Q130146.
- Q3077133 wikiPageWikiLink Q141124.
- Q3077133 wikiPageWikiLink Q1427096.
- Q3077133 wikiPageWikiLink Q158205.
- Q3077133 wikiPageWikiLink Q207722.
- Q3077133 wikiPageWikiLink Q2450337.
- Q3077133 wikiPageWikiLink Q248550.
- Q3077133 wikiPageWikiLink Q309510.
- Q3077133 wikiPageWikiLink Q411114.
- Q3077133 wikiPageWikiLink Q458.
- Q3077133 wikiPageWikiLink Q4677569.
- Q3077133 wikiPageWikiLink Q496.
- Q3077133 wikiPageWikiLink Q506319.
- Q3077133 wikiPageWikiLink Q7071513.
- Q3077133 wikiPageWikiLink Q7180990.
- Q3077133 wikiPageWikiLink Q7211328.
- Q3077133 wikiPageWikiLink Q8253301.
- Q3077133 wikiPageWikiLink Q8277.
- Q3077133 wikiPageWikiLink Q8418463.
- Q3077133 wikiPageWikiLink Q851111.
- Q3077133 wikiPageWikiLink Q9052323.
- Q3077133 wikiPageWikiLink Q9377.
- Q3077133 atcPrefix "L04".
- Q3077133 atcSuffix "AA31".
- Q3077133 casNumber "163451".
- Q3077133 chebi "68540".
- Q3077133 iupacName "-2".
- Q3077133 pubchem "5479847".
- Q3077133 unii "1".
- Q3077133 type ChemicalSubstance.
- Q3077133 type Drug.
- Q3077133 type ChemicalObject.
- Q3077133 type Thing.
- Q3077133 type Q8386.
- Q3077133 comment "Teriflunomide (trade name Aubagio, marketed by Sanofi) is the active metabolite of leflunomide. Teriflunomide was investigated in the Phase III clinical trial TEMSO as a medication for multiple sclerosis (MS). The study was completed in July 2010. 2-year results were positive.".
- Q3077133 label "Teriflunomide".
- Q3077133 depiction Teriflunomide_structure.svg.
